genomic therapies

Digital

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets.

News

Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.